Cargando…
Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use”
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Psychiatric Pharmacists
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337883/ https://www.ncbi.nlm.nih.gov/pubmed/37448830 http://dx.doi.org/10.9740/mhc.2023.06.165 |
_version_ | 1785071511477944320 |
---|---|
author | Still, Daniel Do, Kathy Thompson, Paul Brackins, Todd McGrory, James |
author_facet | Still, Daniel Do, Kathy Thompson, Paul Brackins, Todd McGrory, James |
author_sort | Still, Daniel |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10337883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association of Psychiatric Pharmacists |
record_format | MEDLINE/PubMed |
spelling | pubmed-103378832023-07-13 Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” Still, Daniel Do, Kathy Thompson, Paul Brackins, Todd McGrory, James Ment Health Clin Letter to the Editor American Association of Psychiatric Pharmacists 2023-06-28 /pmc/articles/PMC10337883/ /pubmed/37448830 http://dx.doi.org/10.9740/mhc.2023.06.165 Text en © 2023 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists. https://creativecommons.org/licenses/by-nc/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Still, Daniel Do, Kathy Thompson, Paul Brackins, Todd McGrory, James Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title | Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title_full | Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title_fullStr | Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title_full_unstemmed | Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title_short | Comment on “An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use” |
title_sort | comment on “an update on recently approved long-acting injectable second-generation antipsychotics: knowns and unknowns regarding their use” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337883/ https://www.ncbi.nlm.nih.gov/pubmed/37448830 http://dx.doi.org/10.9740/mhc.2023.06.165 |
work_keys_str_mv | AT stilldaniel commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse AT dokathy commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse AT thompsonpaul commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse AT brackinstodd commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse AT mcgroryjames commentonanupdateonrecentlyapprovedlongactinginjectablesecondgenerationantipsychoticsknownsandunknownsregardingtheiruse |